Bone Grafts Market was valued at USD 3.2 billion and expected to grow at 6.1% Compound Annual Growth Rate (CAGR) over the 2022-2028. Global Bone Grafts Market: Bone grafting is a surgical procedure used to fix the bones or joints. Bone grafting is replacement or repair of bones which are damaged due to trauma or fractures with the bones from other body tissue. For instance, in lumbar surgery bone from the donor site transplanted to recipient site to facilitate the fusion of vertebrae. The grafting tissue is necessary for osteoinduction, a natural bone healing process. The bone grafts are three types’ autologous, allograft, and Synthetic bone. Autologous bone harvested from patients own body, often from the iliac crest. Sallograft is cadaveric bone usually obtained from a bone bank. Synthetic bone made of hydroxyapatite or other naturally occurring, biocompatible substances. Bone grafts have a wide range of applications in sports, trauma plastic, facial, and spinal surgery. The market is expected to grow at steady state during the forecasting period. Companies focusing on product innovations and line extensions to increase their market share. Increasing in geriatric population and growing prevalence of bone and joint disorders are the main factors boosting the market. According to National Osteoporosis Foundation (NOF), it is expected that the number of cases with osteoporosis will exceed 61 Mn by 2020. According to National Spinal Cord Injury Centre in U.S, Researchers have assessed that in 2015, nearly 12,500 new spinal cord injuries have occurred in the year. However, larger players in market are funding bone grafts research, collaborating and acquiring smaller players to increase their market share.
In June 2016, AlloSource announced two new innovative demineralized cortical fiber allografts, the allofuse fiber boat and allofuse cortical fibers for use in a variety of spine and orthopaedic procedures.
In September 2016, RTI Surgical received regulatory clearance from the Australian Therapeutic Goods Administration (TGA) for nanoss bioactive bone void filler in Australia. Furthermore, Venture Capitalists and Government Organisations are actively involved in funding and encouraging the research activities.
In February 2016, Dentsply International, Inc. and Sirona Dental Systems, Inc. are merged to form Dentsply Sirona International.